B BRIDGEBIO PHARMA INC
$73.15
| Market Cap | $14.18B |
| P/E Ratio | — |
| Forward P/E | 36575.00 |
| Dividend Yield | — |
| Beta | 1.09 |
| 52W Range | $30.14 - $79.91 |
| # Hedge Funds | 2 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 2 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Viking Global Investors Viking Global Investors | 2.92% | $1.10B | 14,393,934 | Reduce 9.91% |
| Polen Capital Management Polen Capital Management | 0.01% | $2.92M | 38,241 | Add 5.74% |
Insider Trading
| Insider Name of the company insider who made the trade 113 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Kumar NeilChief Executive Officer | Sale | 9,759 | $69.23 | $675.57K | 13 Mar 2026 | 12 Mar 2026 |
| Kumar NeilChief Executive Officer | Sale | 10,241 | $68.39 | $700.35K | 13 Mar 2026 | 12 Mar 2026 |
| Kumar NeilChief Executive Officer | Sale | 10,310 | $69.20 | $713.45K | 13 Mar 2026 | 12 Mar 2026 |
| Kumar NeilChief Executive Officer | Sale | 9,690 | $68.36 | $662.44K | 13 Mar 2026 | 12 Mar 2026 |
| Kumar NeilChief Executive Officer | Sale | 5,815 | $69.29 | $402.93K | 12 Mar 2026 | 12 Mar 2026 |
| Kumar NeilChief Executive Officer | Sale | 13,885 | $68.47 | $950.69K | 12 Mar 2026 | 12 Mar 2026 |
| Kumar NeilChief Executive Officer | Sale | 300 | $70.15 | $21.05K | 12 Mar 2026 | 12 Mar 2026 |
| Kumar NeilChief Executive Officer | Sale | 5,363 | $69.32 | $371.75K | 12 Mar 2026 | 12 Mar 2026 |
| Kumar NeilChief Executive Officer | Sale | 14,337 | $68.48 | $981.81K | 12 Mar 2026 | 12 Mar 2026 |
| Valantine Hannah | Sale | 8,671 | $72.00 | $624.31K | 10 Mar 2026 | 10 Mar 2026 |
| Ellis Andrea | Sale | 64,921 | $64.87 | $4.21M | 04 Mar 2026 | 06 Mar 2026 |
| Andrea EllisDirector | Sale | 64,921 | $64.87 | $4.21M | 04 Mar 2026 | 06 Mar 2026 |
| Valantine Hannah | Sale | 10,900 | $67.84 | $739.50K | 27 Feb 2026 | 03 Mar 2026 |
| Valantine Hannah | Sale | 14,584 | $67.08 | $978.28K | 27 Feb 2026 | 03 Mar 2026 |
| Apuli MaricelChief Accounting Officer | Sale | 2,000 | $66.00 | $132.00K | 26 Feb 2026 | 27 Feb 2026 |
| Kumar NeilChief Executive Officer | Sale | 602 | $72.80 | $43.83K | 19 Feb 2026 | 23 Feb 2026 |
| Kumar NeilChief Executive Officer | Sale | 8,528 | $72.08 | $614.70K | 19 Feb 2026 | 23 Feb 2026 |
| Kumar NeilChief Executive Officer | Sale | 18,923 | $71.03 | $1.34M | 19 Feb 2026 | 23 Feb 2026 |
| Scott Randal W. | Sale | 3,307 | $75.93 | $251.09K | 17 Feb 2026 | 18 Feb 2026 |
| Scott Randal W. | Sale | 4,793 | $75.57 | $362.22K | 17 Feb 2026 | 18 Feb 2026 |
| Apuli MaricelChief Accounting Officer | Sale | 510 | $74.31 | $37.90K | 17 Feb 2026 | 18 Feb 2026 |
| Scott Randal W. | Sale | 1,900 | $74.34 | $141.25K | 17 Feb 2026 | 18 Feb 2026 |
| Trimarchi ThomasPresident and CFO | Sale | 200 | $75.38 | $15.08K | 17 Feb 2026 | 18 Feb 2026 |
| Trimarchi ThomasPresident and CFO | Sale | 13,400 | $74.71 | $1.00M | 17 Feb 2026 | 18 Feb 2026 |
| Kumar NeilChief Executive Officer | Sale | 4,404 | $72.65 | $319.94K | 11 Feb 2026 | 12 Feb 2026 |
| Kumar NeilChief Executive Officer | Sale | 3,775 | $71.46 | $269.75K | 11 Feb 2026 | 12 Feb 2026 |
| Kumar NeilChief Executive Officer | Sale | 7,860 | $70.70 | $555.71K | 11 Feb 2026 | 12 Feb 2026 |
| Kumar NeilChief Executive Officer | Sale | 3,994 | $73.25 | $292.57K | 11 Feb 2026 | 12 Feb 2026 |
| Kumar NeilChief Executive Officer | Sale | 4,484 | $72.64 | $325.70K | 11 Feb 2026 | 12 Feb 2026 |
| Kumar NeilChief Executive Officer | Sale | 3,961 | $73.25 | $290.15K | 11 Feb 2026 | 12 Feb 2026 |
| Kumar NeilChief Executive Officer | Sale | 3,716 | $71.44 | $265.48K | 11 Feb 2026 | 12 Feb 2026 |
| Kumar NeilChief Executive Officer | Sale | 7,806 | $70.69 | $551.80K | 11 Feb 2026 | 12 Feb 2026 |
| Kumar NeilChief Executive Officer | Sale | 5,960 | $72.27 | $430.75K | 10 Feb 2026 | 12 Feb 2026 |
| Kumar NeilChief Executive Officer | Sale | 14,040 | $71.80 | $1.01M | 10 Feb 2026 | 12 Feb 2026 |
| Kumar NeilChief Executive Officer | Sale | 5,799 | $72.28 | $419.17K | 10 Feb 2026 | 12 Feb 2026 |
| Kumar NeilChief Executive Officer | Sale | 14,201 | $71.80 | $1.02M | 10 Feb 2026 | 12 Feb 2026 |
| Kumar NeilChief Executive Officer | Sale | 1,855 | $78.10 | $144.88K | 09 Jan 2026 | 12 Jan 2026 |
| Kumar NeilChief Executive Officer | Sale | 10,677 | $77.46 | $827.02K | 09 Jan 2026 | 12 Jan 2026 |
| Kumar NeilChief Executive Officer | Sale | 375 | $78.19 | $29.32K | 09 Jan 2026 | 12 Jan 2026 |
| Kumar NeilChief Executive Officer | Sale | 6,955 | $76.72 | $533.57K | 09 Jan 2026 | 12 Jan 2026 |
| Kumar NeilChief Executive Officer | Sale | 6,067 | $76.53 | $464.29K | 09 Jan 2026 | 12 Jan 2026 |
| Kumar NeilChief Executive Officer | Sale | 1,401 | $75.61 | $105.93K | 09 Jan 2026 | 12 Jan 2026 |
| Kumar NeilChief Executive Officer | Sale | 10,519 | $77.61 | $816.36K | 09 Jan 2026 | 12 Jan 2026 |
| Kumar NeilChief Executive Officer | Sale | 2,151 | $75.75 | $162.94K | 09 Jan 2026 | 12 Jan 2026 |
| Kumar NeilChief Executive Officer | Sale | 8,135 | $74.38 | $605.06K | 08 Jan 2026 | 12 Jan 2026 |
| Kumar NeilChief Executive Officer | Sale | 8,085 | $74.38 | $601.34K | 08 Jan 2026 | 12 Jan 2026 |
| Kumar NeilChief Executive Officer | Sale | 300 | $75.20 | $22.56K | 08 Jan 2026 | 12 Jan 2026 |
| Kumar NeilChief Executive Officer | Sale | 11,565 | $73.65 | $851.81K | 08 Jan 2026 | 12 Jan 2026 |
| Kumar NeilChief Executive Officer | Sale | 400 | $75.16 | $30.06K | 08 Jan 2026 | 12 Jan 2026 |
| Kumar NeilChief Executive Officer | Sale | 11,515 | $73.64 | $848.02K | 08 Jan 2026 | 12 Jan 2026 |
| Kumar NeilChief Executive Officer | Sale | 1,700 | $75.24 | $127.91K | 15 Dec 2025 | 16 Dec 2025 |
| Kumar NeilChief Executive Officer | Sale | 28,311 | $74.60 | $2.11M | 15 Dec 2025 | 16 Dec 2025 |
| Apuli MaricelChief Accounting Officer | Sale | 2,000 | $74.26 | $148.52K | 08 Dec 2025 | 10 Dec 2025 |
| Kumar NeilChief Executive Officer | Sale | 7,712 | $73.75 | $568.76K | 05 Dec 2025 | 08 Dec 2025 |
| Kumar NeilChief Executive Officer | Sale | 12,288 | $73.04 | $897.53K | 05 Dec 2025 | 08 Dec 2025 |
| Kumar NeilChief Executive Officer | Sale | 7,483 | $73.76 | $551.95K | 05 Dec 2025 | 08 Dec 2025 |
| Kumar NeilChief Executive Officer | Sale | 12,517 | $73.05 | $914.32K | 05 Dec 2025 | 08 Dec 2025 |
| Kumar NeilChief Executive Officer | Sale | 5,700 | $74.80 | $426.36K | 04 Dec 2025 | 08 Dec 2025 |
| Kumar NeilChief Executive Officer | Sale | 12,200 | $74.42 | $907.97K | 04 Dec 2025 | 08 Dec 2025 |
| Kumar NeilChief Executive Officer | Sale | 2,100 | $73.16 | $153.63K | 04 Dec 2025 | 08 Dec 2025 |
| Kumar NeilChief Executive Officer | Sale | 5,708 | $74.80 | $426.94K | 04 Dec 2025 | 08 Dec 2025 |
| Kumar NeilChief Executive Officer | Sale | 2,100 | $73.16 | $153.64K | 04 Dec 2025 | 08 Dec 2025 |
| Kumar NeilChief Executive Officer | Sale | 12,192 | $74.42 | $907.38K | 04 Dec 2025 | 08 Dec 2025 |
| Kumar NeilChief Executive Officer | Sale | 5,456 | $66.71 | $363.99K | 20 Nov 2025 | 24 Nov 2025 |
| Kumar NeilChief Executive Officer | Sale | 14,299 | $65.90 | $942.36K | 20 Nov 2025 | 24 Nov 2025 |
| Kumar NeilChief Executive Officer | Sale | 6,401 | $64.97 | $415.88K | 20 Nov 2025 | 24 Nov 2025 |
| Neil KumarChief Executive Officer | Sale | 6,401 | $64.97 | $415.88K | 20 Nov 2025 | 24 Nov 2025 |
| Neil KumarChief Executive Officer | Sale | 5,456 | $66.71 | $363.99K | 20 Nov 2025 | 24 Nov 2025 |
| Neil KumarChief Executive Officer | Sale | 14,299 | $65.90 | $942.36K | 20 Nov 2025 | 24 Nov 2025 |
| Lo Andrew | Sale | 24,007 | $65.23 | $1.57M | 18 Nov 2025 | 19 Nov 2025 |
| Lo Andrew | Sale | 30,993 | $66.05 | $2.05M | 18 Nov 2025 | 19 Nov 2025 |
| Andrew LoDirector | Sale | 30,993 | $66.05 | $2.05M | 18 Nov 2025 | 19 Nov 2025 |
| Andrew LoDirector | Sale | 24,007 | $65.23 | $1.57M | 18 Nov 2025 | 19 Nov 2025 |
| Lo Andrew | Sale | 36,801 | $66.63 | $2.45M | 17 Nov 2025 | 19 Nov 2025 |
| Trimarchi ThomasPresident and CFO | Sale | 6,956 | $66.84 | $464.94K | 17 Nov 2025 | 18 Nov 2025 |
| Lo Andrew | Sale | 3,798 | $67.06 | $254.68K | 17 Nov 2025 | 19 Nov 2025 |
| Scott Randal W. | Sale | 6,199 | $66.89 | $414.66K | 17 Nov 2025 | 19 Nov 2025 |
| Scott Randal W. | Sale | 3,801 | $66.25 | $251.81K | 17 Nov 2025 | 19 Nov 2025 |
| Trimarchi ThomasPresident and CFO | Sale | 9,978 | $66.19 | $660.47K | 17 Nov 2025 | 18 Nov 2025 |
| Randal W. ScottDirector | Sale | 6,199 | $66.89 | $414.66K | 17 Nov 2025 | 19 Nov 2025 |
| Andrew LoDirector | Sale | 3,798 | $67.06 | $254.68K | 17 Nov 2025 | 19 Nov 2025 |
| Andrew LoDirector | Sale | 36,801 | $66.63 | $2.45M | 17 Nov 2025 | 19 Nov 2025 |
| Randal W. ScottDirector | Sale | 3,801 | $66.25 | $251.81K | 17 Nov 2025 | 19 Nov 2025 |
| Valantine Hannah | Sale | 25,484 | $66.07 | $1.68M | 12 Nov 2025 | 14 Nov 2025 |
| Kumar NeilChief Executive Officer | Sale | 220 | $62.79 | $13.81K | 07 Nov 2025 | 10 Nov 2025 |
| Kumar NeilChief Executive Officer | Sale | 7,546 | $61.87 | $466.84K | 07 Nov 2025 | 10 Nov 2025 |
| Kumar NeilChief Executive Officer | Sale | 12,234 | $61.13 | $747.86K | 07 Nov 2025 | 10 Nov 2025 |
| Kumar NeilChief Executive Officer | Sale | 200 | $62.81 | $12.56K | 07 Nov 2025 | 10 Nov 2025 |
| Kumar NeilChief Executive Officer | Sale | 12,492 | $61.14 | $763.76K | 07 Nov 2025 | 10 Nov 2025 |
| Kumar NeilChief Executive Officer | Sale | 7,308 | $61.87 | $452.16K | 07 Nov 2025 | 10 Nov 2025 |
| Kumar NeilChief Executive Officer | Sale | 12,529 | $62.91 | $788.18K | 06 Nov 2025 | 10 Nov 2025 |
| Kumar NeilChief Executive Officer | Sale | 7,324 | $63.55 | $465.42K | 06 Nov 2025 | 10 Nov 2025 |
| Kumar NeilChief Executive Officer | Sale | 12,576 | $62.91 | $791.17K | 06 Nov 2025 | 10 Nov 2025 |
| DANIELS RONALD J | Sale | 61,031 | $63.72 | $3.89M | 06 Nov 2025 | 07 Nov 2025 |
| Kumar NeilChief Executive Officer | Sale | 7,371 | $63.56 | $468.47K | 06 Nov 2025 | 10 Nov 2025 |
| Kumar NeilChief Executive Officer | Sale | 100 | $64.39 | $6.44K | 06 Nov 2025 | 10 Nov 2025 |
| MCCORMICK FRANK | Sale | 8,598 | $68.50 | $588.99K | 29 Oct 2025 | 31 Oct 2025 |
| MCCORMICK FRANK | Sale | 43,393 | $69.24 | $3.00M | 29 Oct 2025 | 31 Oct 2025 |
| MCCORMICK FRANK | Sale | 3,497 | $67.52 | $236.13K | 29 Oct 2025 | 31 Oct 2025 |
| MCCORMICK FRANK | Sale | 31,116 | $66.20 | $2.06M | 29 Oct 2025 | 31 Oct 2025 |
| MCCORMICK FRANK | Sale | 111,755 | $65.48 | $7.32M | 29 Oct 2025 | 31 Oct 2025 |
| Frank MccormickDirector | Sale | 43,393 | $69.24 | $3.00M | 29 Oct 2025 | 31 Oct 2025 |
| Frank MccormickDirector | Sale | 111,755 | $65.48 | $7.32M | 29 Oct 2025 | 31 Oct 2025 |
| Frank MccormickDirector | Sale | 8,598 | $68.50 | $588.99K | 29 Oct 2025 | 31 Oct 2025 |
| Frank MccormickDirector | Sale | 3,497 | $67.52 | $236.13K | 29 Oct 2025 | 31 Oct 2025 |
| Frank MccormickDirector | Sale | 31,116 | $66.20 | $2.06M | 29 Oct 2025 | 31 Oct 2025 |
| MCCORMICK FRANK | Sale | 1,641 | $65.00 | $106.67K | 27 Oct 2025 | 29 Oct 2025 |
| Frank MccormickDirector | Sale | 1,641 | $65.00 | $106.67K | 27 Oct 2025 | 29 Oct 2025 |
| Kumar NeilChief Executive Officer | Sale | 20,000 | $54.80 | $1.10M | 09 Oct 2025 | 10 Oct 2025 |
| Kumar NeilChief Executive Officer | Sale | 11,294 | $55.09 | $622.17K | 08 Oct 2025 | 10 Oct 2025 |
| Kumar NeilChief Executive Officer | Sale | 8,706 | $54.39 | $473.50K | 08 Oct 2025 | 10 Oct 2025 |
| Kumar NeilChief Executive Officer | Sale | 11,295 | $55.09 | $622.23K | 08 Oct 2025 | 10 Oct 2025 |
| Kumar NeilChief Executive Officer | Sale | 8,705 | $54.39 | $473.45K | 08 Oct 2025 | 10 Oct 2025 |
Frequently Asked Questions
What is BBIO stock price today?
BRIDGEBIO PHARMA INC (BBIO) is currently trading at $73.15. The stock has a 52-week range of $30.14 to $79.91 and a market capitalization of $14.18B.
Is BBIO a good stock to buy in 2026?
BRIDGEBIO PHARMA INC has a P/E ratio of N/A (forward P/E: 36575.0), a dividend yield of none, and 1-year performance of +114.7%. 2 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling BBIO stock?
There have been 113 insider transactions for BBIO in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has BBIO stock performed over the past year?
BRIDGEBIO PHARMA INC (BBIO) has returned +114.7% over the past 12 months. The stock traded between $30.14 and $79.91 during this period, and is currently at $73.15.
Which hedge funds own BBIO (BRIDGEBIO PHARMA INC)?
2 tracked hedge funds currently hold BBIO in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is BBIO's market cap and valuation?
BRIDGEBIO PHARMA INC (BBIO) has a market capitalization of $14.18B. The trailing P/E ratio is N/A and forward P/E is 36575.0. The stock is classified in the Healthcare sector.
What is BBIO's revenue and profitability?
BRIDGEBIO PHARMA INC reported revenue of $502.08M with net income of N/A and a profit margin of N/A. The stock has a beta of 1.09.
What sector is BBIO in and who are its biggest institutional holders?
BRIDGEBIO PHARMA INC (BBIO) operates in the Healthcare sector. It is held by 2 tracked hedge funds. See the ownership table above for the complete list.